Recent Developments in Cancer Systems Biology

This ebook includes original research articles and reviews to update readers on the state of the art systems approach to not only discover novel diagnostic and prognostic biomarkers for several cancer types, but also evaluate methodologies to map out important genomic signatures. In addition, therap...

Descrición completa

Gardado en:
Detalles Bibliográficos
Formato: Online
Idioma:inglés
Publicado: MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Acceso en liña:ONIX_20220111_9783036514727_455
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
_version_ 1869528962075459584
collection Directory of Open Access Books
description This ebook includes original research articles and reviews to update readers on the state of the art systems approach to not only discover novel diagnostic and prognostic biomarkers for several cancer types, but also evaluate methodologies to map out important genomic signatures. In addition, therapeutic targets and drug repurposing have been emphasized for a variety of cancer types. In particular, new and established researchers who desire to learn about cancer systems biology and why it is possibly the leading front to a personalized medicine approach will enjoy reading this book.
format Online
id doab-20.500.12854ir-76720
institution Directory of Open Access Books
language eng
publishDate 2022
publishDateRange 2022
publishDateSort 2022
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-767202024-03-31T13:10:02Z Recent Developments in Cancer Systems Biology Sinha, Raghu Arga, Kazim Yalcin Sestrin2 lung cancer knockdown cancer progression bioinformatics patient survival lung adenocarcinoma circulating miR-1246 glycosaminoglycan binding prognosis PI3K–Akt signaling pathways TargetScan UBE2C cancer systems biology experimental model systems next-generation sequencing single-cell sequencing patient-derived xenografts patient-derived organoids triple-negative breast cancer personalized medicine computational methods drug repurposing clinical trials cancer stem cells ETS Elk-1 stem cell microarray brain-tumor-initiating cell (BTIC) pancreatic cancer systems biology omics biomarker genomics transcriptomics proteomics metabolomics glycomics metagenomics Ets PEA3 Ets-1 glioma optical genome mapping solid tumors cancer genomics breast ovarian cancer TCGA non-small-cell lung cancer lung adenocarcinoma (LUAD) lung squamous cell carcinoma (LUSC) differential expression SNV CNV risk group signature survival renal cancers protein interactome diagnostic biomarker prognostic biomarker virtual screening docking acute myeloid leukemia Boolean model drug resistance network n/a thema EDItEUR::M Medicine and Nursing This ebook includes original research articles and reviews to update readers on the state of the art systems approach to not only discover novel diagnostic and prognostic biomarkers for several cancer types, but also evaluate methodologies to map out important genomic signatures. In addition, therapeutic targets and drug repurposing have been emphasized for a variety of cancer types. In particular, new and established researchers who desire to learn about cancer systems biology and why it is possibly the leading front to a personalized medicine approach will enjoy reading this book. 2022-01-11T13:40:05Z 2022-01-11T13:40:05Z 2021 book ONIX_20220111_9783036514727_455 9783036514727 9783036514710 https://directory.doabooks.org/handle/20.500.12854/76720 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/4169 https://mdpi.com/books/pdfview/book/4169 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-1471-0 10.3390/books978-3-0365-1471-0 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036514727 9783036514710 272 Basel, Switzerland open access
spellingShingle Sestrin2
lung cancer
knockdown
cancer progression
bioinformatics
patient survival
lung adenocarcinoma
circulating miR-1246
glycosaminoglycan binding
prognosis
PI3K–Akt signaling pathways
TargetScan
UBE2C
cancer systems biology
experimental model systems
next-generation sequencing
single-cell sequencing
patient-derived xenografts
patient-derived organoids
triple-negative breast cancer
personalized medicine
computational methods
drug repurposing
clinical trials
cancer stem cells
ETS
Elk-1
stem cell
microarray
brain-tumor-initiating cell (BTIC)
pancreatic cancer
systems biology
omics
biomarker
genomics
transcriptomics
proteomics
metabolomics
glycomics
metagenomics
Ets
PEA3
Ets-1
glioma
optical genome mapping
solid tumors
cancer genomics
breast
ovarian
cancer
TCGA
non-small-cell lung cancer
lung adenocarcinoma (LUAD)
lung squamous cell carcinoma (LUSC)
differential expression
SNV
CNV
risk group
signature
survival
renal cancers
protein interactome
diagnostic biomarker
prognostic biomarker
virtual screening
docking
acute myeloid leukemia
Boolean model
drug resistance
network
n/a
thema EDItEUR::M Medicine and Nursing
Recent Developments in Cancer Systems Biology
title Recent Developments in Cancer Systems Biology
title_full Recent Developments in Cancer Systems Biology
title_fullStr Recent Developments in Cancer Systems Biology
title_full_unstemmed Recent Developments in Cancer Systems Biology
title_short Recent Developments in Cancer Systems Biology
title_sort recent developments in cancer systems biology
topic Sestrin2
lung cancer
knockdown
cancer progression
bioinformatics
patient survival
lung adenocarcinoma
circulating miR-1246
glycosaminoglycan binding
prognosis
PI3K–Akt signaling pathways
TargetScan
UBE2C
cancer systems biology
experimental model systems
next-generation sequencing
single-cell sequencing
patient-derived xenografts
patient-derived organoids
triple-negative breast cancer
personalized medicine
computational methods
drug repurposing
clinical trials
cancer stem cells
ETS
Elk-1
stem cell
microarray
brain-tumor-initiating cell (BTIC)
pancreatic cancer
systems biology
omics
biomarker
genomics
transcriptomics
proteomics
metabolomics
glycomics
metagenomics
Ets
PEA3
Ets-1
glioma
optical genome mapping
solid tumors
cancer genomics
breast
ovarian
cancer
TCGA
non-small-cell lung cancer
lung adenocarcinoma (LUAD)
lung squamous cell carcinoma (LUSC)
differential expression
SNV
CNV
risk group
signature
survival
renal cancers
protein interactome
diagnostic biomarker
prognostic biomarker
virtual screening
docking
acute myeloid leukemia
Boolean model
drug resistance
network
n/a
thema EDItEUR::M Medicine and Nursing
topic_facet Sestrin2
lung cancer
knockdown
cancer progression
bioinformatics
patient survival
lung adenocarcinoma
circulating miR-1246
glycosaminoglycan binding
prognosis
PI3K–Akt signaling pathways
TargetScan
UBE2C
cancer systems biology
experimental model systems
next-generation sequencing
single-cell sequencing
patient-derived xenografts
patient-derived organoids
triple-negative breast cancer
personalized medicine
computational methods
drug repurposing
clinical trials
cancer stem cells
ETS
Elk-1
stem cell
microarray
brain-tumor-initiating cell (BTIC)
pancreatic cancer
systems biology
omics
biomarker
genomics
transcriptomics
proteomics
metabolomics
glycomics
metagenomics
Ets
PEA3
Ets-1
glioma
optical genome mapping
solid tumors
cancer genomics
breast
ovarian
cancer
TCGA
non-small-cell lung cancer
lung adenocarcinoma (LUAD)
lung squamous cell carcinoma (LUSC)
differential expression
SNV
CNV
risk group
signature
survival
renal cancers
protein interactome
diagnostic biomarker
prognostic biomarker
virtual screening
docking
acute myeloid leukemia
Boolean model
drug resistance
network
n/a
thema EDItEUR::M Medicine and Nursing
url ONIX_20220111_9783036514727_455